Media

Event
Medical
Corporate
Corporate
2021-01-18

Taiwan Healthcare Data Preservation Platform Initiative

The Taiwan government has established a four-year "Taiwan Healthcare Data Preservation Platform" from this year. It is jointly funded by the Ministry of Science and Technology, the Ministry of Health and Welfare, and the Ministry of Economic Affairs. The

Published:

Taiwan

Author(s):

Corporate
2020-12-29

Nan Shan Life Insurance Dedicated To Promote Health Management Across Industries

Nan Shan Life Insurance invites business partners include Remark, Health2Sync, GHS Advanced, Ideabus Technology , ACT Genomics, Med-net, Inventec Appliances , Pau Yuen Trading and Cofit Healthcare to share cooperation experiences and provide more compre

Published:

Taipei

Author(s):

Healthnews

Medical
2020-12-22

Precision medicine enables urothelial carcinoma patient to be treated with targeted therapy for renal cancer

One patient's urothelial carcinoma progressed rapidly while surgery and chemotherapy were ineffective. Two genomic mutations were found through genomic profiling, and targeted therapy for renal cancer was used to control cancer.

Published:

Taipei

Author(s):

Healthnews

Corporate
2020-10-21

Business Opportunities in Genomics – Immunotherapy & biomarkers

Microsatellite instability (MSI) and Tumor Mutational Burden (TMB) are two important biomarkers to predict the response of immunotherapy. ACT Genomics is dedicated to optimize the accuracy of TMB testing in Friends of Cancer Research (FoCR) Global Project

Published:

Hong Kong

Author(s):

Dr. Hua-Chien Chen

Corporate
2020-10-05

Business Opportunities in Genomics — ACT Genomics co-organizes Hong Kong International Oncology Symposium

ACT Genomics is honored to be the coorganizer of The 7th HKIOS, to dedicate in the cancer precision medicine and to build a more health society.

Published:

Hong Kong

Author(s):

Dr. Hua-Chien Chen

Corporate
2020-10-01

Business Opportunities in Genomics — Provide discounts on cancer genomic profiling for insurance plan

To broaden the application of cancer genomic profiling and enable more cancer patients to use advanced medical technology, ACT Genomics continues the cooperation with AIA Hong Kong and provide discounts on cancer genomic profiling for one year program.

Published:

Hong Kong

Author(s):

Dr. Hua-Chien Chen

Corporate
2020-09-30

Upgrade of Cancer Prevention Insurance

Physicians can start appropriate treatment strategy according to cancer genomic mutation and ACT Genomics will provide 10 % discounts on all ACT Genomics cancer genomic profiling items to 2021.09.25

Published:

Taipei

Author(s):

Economy Daily News

Medical
2020-09-16

Genomic sequencing helps the combination of two immune checkpoint inhibitors to control stage IV nasopharyngeal carcinoma

A cancer patient is identified by comprehensive genomic profiling as TMB-H with better response to immunotherapy and the combination of two immune checkpoint inhibitors is used to control stage IV nasopharyngeal carcinoma successfully

Published:

Taipei

Author(s):

HealthNews

Corporate
2020-09-08

Business Opportunities in Genomics — A big difference in Eastern & Western melanoma patients

Immunotherapy shows better efficacy in Western melanoma patients than Asian patients. ACT Genomics cooperates with medical institutes to understand the molecular information of melanoma for better treatment.

Published:

Hong Kong

Author(s):

Dr. Hua -Chien Chen

Corporate
2020-08-24

Business Opportunities in Genomics-NGS can help evaluating immunotherapy

Via Next Generation Sequencing, TMB-H cancer patients have positive progress after using immunotherapy

Published:

Hong Kong

Author(s):

Dr. Hua-Chien Chen

日韩av电影,色YEYE高清在线视频,欧美XXZOZO,JAPANESE 18日本护士